International Biophysics Corp. recently announced that the company will now manufacture its AffloVest in the United States. AffloVest is the first portable High Frequency Chest Wall Oscillation (HFCWO) medical device which can provide critical treatment for patients with cystic fibrosis, bronchiectasis, and other respiratory conditions.
In the past, many U.S. companies took their manufacturing facilities abroad, mainly because of tax lower wages and tax advantages. But companies are reconsidering this strategy due to changes in the world economy.
